Published in Brain Res Mol Brain Res on July 01, 1992
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
Dopamine, behavioral economics, and effort. Front Behav Neurosci (2009) 1.91
Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol (2007) 1.90
Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol (1996) 1.72
Priorities in Parkinson's disease research. Nat Rev Drug Discov (2011) 1.66
Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. Proc Natl Acad Sci U S A (1995) 1.64
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci (2008) 1.63
Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice. PLoS One (2009) 1.61
Deletion of GAD67 in dopamine receptor-1 expressing cells causes specific motor deficits. Genesis (2008) 1.42
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci U S A (2001) 1.37
The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. J Exp Anal Behav (2012) 1.33
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A (2000) 1.30
Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl) (2010) 1.27
Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum. Biotechniques (2011) 1.27
What is the Degree of Segregation between Striatonigral and Striatopallidal Projections? Front Neuroanat (2010) 1.21
Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors. J Biol Chem (1994) 1.16
Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway. ScientificWorldJournal (2009) 1.16
125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor. Mol Pharmacol (1995) 1.13
Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proc Natl Acad Sci U S A (1996) 1.13
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. J Neural Transm (Vienna) (2011) 1.12
Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning. J Neurosci (2009) 1.11
Distribution and compartmental organization of GABAergic medium-sized spiny neurons in the mouse nucleus accumbens. Front Neural Circuits (2013) 1.09
Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats. Psychopharmacology (Berl) (2008) 1.06
Adenosine and sleep. Curr Neuropharmacol (2009) 1.05
Protein kinases and addiction. Ann N Y Acad Sci (2008) 1.05
Dopamine and glutamate in Huntington's disease: A balancing act. CNS Neurosci Ther (2010) 1.03
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc Natl Acad Sci U S A (2003) 1.03
Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology (2011) 1.02
Sensitivity to cognitive effort mediates psychostimulant effects on a novel rodent cost/benefit decision-making task. Neuropsychopharmacology (2012) 1.02
Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32. Neuropsychopharmacology (2011) 1.00
Genetics and neuropathology of Huntington's disease. Int Rev Neurobiol (2011) 0.99
Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology (2009) 0.98
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiol Dis (2010) 0.95
The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology (Berl) (2008) 0.95
Indirect basal ganglia pathway mediation of repetitive behavior: attenuation by adenosine receptor agonists. Behav Brain Res (2010) 0.94
The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure. Psychopharmacology (Berl) (2009) 0.94
Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats. Behav Brain Res (2006) 0.94
Effects of caffeine on alcohol consumption and nicotine self-administration in rats. Alcohol Clin Exp Res (2013) 0.94
Mechanisms of induction of adenosine receptor genes and its functional significance. J Cell Physiol (2009) 0.92
Adenosine A(2A) receptor enhances GABA(A)-mediated IPSCs in the rat globus pallidus. J Physiol (2001) 0.92
Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience (2010) 0.91
Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats. Neuropsychopharmacology (2011) 0.90
Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes. Br J Pharmacol (1993) 0.89
Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection. Pediatr Res (2011) 0.89
Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 0.89
G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol (2015) 0.88
Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice. Psychopharmacology (Berl) (2009) 0.88
Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal. Alcohol Clin Exp Res (2011) 0.88
Effects of adenosine A2A receptor stimulation on cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2009) 0.88
Receptor crosstalk: haloperidol treatment enhances A(2A) adenosine receptor functioning in a transfected cell model. Purinergic Signal (2010) 0.87
Control of striatal signaling by g protein regulators. Front Neuroanat (2011) 0.87
Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism. Parkinsonism Relat Disord (2008) 0.87
Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's disease. Neurotherapeutics (2009) 0.86
Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice. J Biomed Sci (2010) 0.86
Dopamine/adenosine interactions involved in effort-related aspects of food motivation. Appetite (2009) 0.86
Adenosine A(2A) receptors in Parkinson's disease treatment. Purinergic Signal (2008) 0.86
Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A(2A) receptor knockout mice. Br J Pharmacol (2008) 0.85
Adenosine A(2A) Receptor Antagonists and Parkinson's Disease. ACS Chem Neurosci (2011) 0.84
Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.84
Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling. Front Neuroanat (2011) 0.84
Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats. ACS Chem Neurosci (2013) 0.84
Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum. J Comp Neurol (2012) 0.84
Regulation of cardiovascular development by adenosine and adenosine-mediated embryo protection. Arterioscler Thromb Vasc Biol (2012) 0.83
Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition. Curr Neuropharmacol (2009) 0.83
Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology (Berl) (2011) 0.83
Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex. Br J Pharmacol (1995) 0.83
The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat. Psychopharmacology (Berl) (2008) 0.83
Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways. Exp Brain Res (2005) 0.83
The potential of caffeine for functional modification from cortical synapses to neuron networks in the brain. Curr Neuropharmacol (2005) 0.82
D2-like dopamine and β-adrenergic receptors form a signaling complex that integrates Gs- and Gi-mediated regulation of adenylyl cyclase. Cell Signal (2012) 0.82
Effects of P(1) and P2 receptor antagonists on beta, gamma-methyleneATP- and CGS21680-induced cyclic AMP formation in NG108-15 cells. Br J Pharmacol (2000) 0.81
Chronic hypoxia reduces adenosine A2A receptor-mediated inhibition of calcium current in rat PC12 cells via downregulation of protein kinase A. J Physiol (1998) 0.81
Dopamine receptors and Parkinson's disease. Int J Med Chem (2011) 0.81
Projections of nucleus accumbens adenosine A2A receptor neurons in the mouse brain and their implications in mediating sleep-wake regulation. Front Neuroanat (2013) 0.81
Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding. Arch Biochem Biophys (1993) 0.81
Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl) (2011) 0.81
Adenosine receptor expression and function in rat striatal cholinergic interneurons. Br J Pharmacol (2000) 0.81
Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia. Neurol Sci (2015) 0.80
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease. PLoS One (2014) 0.80
Time and sex-dependent effects of an adenosine A2A/A1 receptor antagonist on motivation to self-administer cocaine in rats. Pharmacol Biochem Behav (2012) 0.80
Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse. Prog Mol Biol Transl Sci (2013) 0.80
Thalamocortical dynamics of sleep: roles of purinergic neuromodulation. Semin Cell Dev Biol (2011) 0.79
Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat. Psychopharmacology (Berl) (2010) 0.79
Inhibitory deficit in schizophrenia is not necessarily a GABAergic deficit. Cell Mol Neurobiol (2002) 0.79
Persistent reduction of cocaine seeking by pharmacological manipulation of adenosine A1 and A 2A receptors during extinction training in rats. Psychopharmacology (Berl) (2014) 0.79
Differential effects of the adenosine A₂A agonist CGS-21680 and haloperidol on food-reinforced fixed ratio responding in the rat. Psychopharmacology (Berl) (2011) 0.79
mGlu5 Receptor Functional Interactions and Addiction. Front Pharmacol (2012) 0.79
Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling. Brain Res (2006) 0.77
GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation. Neuropharmacology (2016) 0.76
Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia. Mediators Inflamm (2014) 0.76
Sensing Positive versus Negative Reward Signals through Adenylyl Cyclase-Coupled GPCRs in Direct and Indirect Pathway Striatal Medium Spiny Neurons. J Neurosci (2015) 0.76
Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425. Nucl Med Biol (2011) 0.75
Binding of the Antagonist Caffeine to the Human Adenosine Receptor hA2AR in Nearly Physiological Conditions. PLoS One (2015) 0.75
Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia. Exp Neurol (2016) 0.75
mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias. Curr Neuropharmacol (2016) 0.75
A(2A) Receptor Antagonism and Dyskinesia in Parkinson's Disease. Parkinsons Dis (2012) 0.75
mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell (1999) 8.38
Posttranslational mechanisms regulate the mammalian circadian clock. Cell (2001) 7.93
Interacting molecular loops in the mammalian circadian clock. Science (2000) 6.90
Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol (2001) 6.76
Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron (1995) 5.70
Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron (2001) 5.36
Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron (1998) 4.51
A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell (1999) 4.08
Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei. Neuron (1997) 3.60
Cellular construction of a circadian clock: period determination in the suprachiasmatic nuclei. Cell (1997) 3.19
CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev (2000) 2.84
Analysis of clock proteins in mouse SCN demonstrates phylogenetic divergence of the circadian clockwork and resetting mechanisms. Neuron (2000) 2.83
Targeted disruption of the mPer3 gene: subtle effects on circadian clock function. Mol Cell Biol (2000) 2.69
Etidronate therapy for hypercalcemia in subcutaneous fat necrosis of the newborn. J Pediatr (1999) 2.60
Catastrophic failure of a cemented, collarless, polished, tapered cobalt-chromium femoral stem used with impaction bone-grafting. A report of two cases. J Bone Joint Surg Am (1999) 2.19
Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses. Neuron (1990) 2.15
Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron (1994) 1.95
Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development (2001) 1.95
Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A (1995) 1.94
GABA synchronizes clock cells within the suprachiasmatic circadian clock. Neuron (2000) 1.90
The calcium signal for transmitter secretion from presynaptic nerve terminals. Ann N Y Acad Sci (1991) 1.87
The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem (1995) 1.85
Differential regulation of mPER1 and mTIM proteins in the mouse suprachiasmatic nuclei: new insights into a core clock mechanism. J Neurosci (1999) 1.78
Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron (1997) 1.78
Clinical aspects of vasectomies performed in the United States in 1995. Urology (1998) 1.74
Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol (1991) 1.68
Molecular analysis of mammalian timeless. Neuron (1998) 1.60
Keeping time with the human genome. Nature (2001) 1.56
Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol (1992) 1.55
A time-less function for mouse timeless. Nat Neurosci (2000) 1.53
Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: report of two cases. Anesth Analg (2001) 1.52
Home monitoring of 17 hydroxyprogesterone levels in congenitx127drenal hyperplasia with filter paper blood samples. J Pediatr (1999) 1.45
Regulation of mu opioid receptor mRNA levels by activation of protein kinase C in human SH-SY5Y neuroblastoma cells. Anesthesiology (1997) 1.40
Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution. Mol Pharmacol (1993) 1.40
Circadian clock neurons in the silkmoth Antheraea pernyi: novel mechanisms of Period protein regulation. Neuron (1996) 1.36
Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells. Nature (1984) 1.31
Putative melatonin receptors in a human biological clock. Science (1988) 1.31
Discovery of a putative heme-binding protein family (SOUL/HBP) by two-tissue suppression subtractive hybridization and database searches. Brain Res Mol Brain Res (1999) 1.27
Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res (1997) 1.27
Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci U S A (1994) 1.23
Expression of basic helix-loop-helix/PAS genes in the mouse suprachiasmatic nucleus. Neuroscience (1999) 1.22
Accuracy and reproducibility of clinical measures of testicular volume. J Pediatr (1987) 1.17
Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron (1995) 1.15
The suprachiasmatic nuclei of the fetal rat: characterization of a functional circadian clock using 14C-labeled deoxyglucose. J Neurosci (1984) 1.13
Preventing cervical cancer in low-resource settings: how far have we come and what does the future hold? Int J Gynaecol Obstet (2005) 1.10
Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography. J Neurosci (1989) 1.10
Suprachiasmatic nucleus vasopressin messenger RNA: circadian variation in normal and Brattleboro rats. Science (1986) 1.10
Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding. Mol Pharmacol (1996) 1.08
Cloning of a melatonin-related receptor from human pituitary. FEBS Lett (1996) 1.07
Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci (1996) 1.06
Forward genetic approach strikes gold: cloning of a mammalian clock gene. Cell (1997) 1.06
Ontogeny of humoral heart rate regulation in the embryonic mouse. Am J Physiol Regul Integr Comp Physiol (2001) 1.05
Effects of damage to the suprachiasmatic area of the anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey. J Neurosci (1981) 1.04
Melatonin madness. Cell (1995) 1.03
Comparing clockworks: mouse versus fly. J Biol Rhythms (2000) 1.03
Plasma melatonin increases during exercise in women. J Clin Endocrinol Metab (1981) 1.03
RFL9 encodes an A2b-adenosine receptor. Mol Endocrinol (1992) 1.02
Nature's knockout: the Mel1b receptor is not necessary for reproductive and circadian responses to melatonin in Siberian hamsters. Mol Endocrinol (1996) 1.02
Subtrochanteric femoral shortening osteotomy in total hip arthroplasty for high-riding developmental dislocation of the hip. J Arthroplasty (1997) 1.02
Endurance training effects on plasma hormonal responsiveness and sex hormone excretion. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.01
Calcium channels and calcium-gated potassium channels at the frog neuromuscular junction. J Physiol Paris (1993) 1.01
The hypothalamic suprachiasmatic nuclei: circadian patterns of vasopressin secretion and neuronal activity in vitro. Brain Res Bull (1987) 1.00
In vivo metabolic activity of the suprachiasmatic nuclei: a comparative study. Brain Res (1983) 0.99
Differential expression of the apurinic / apyrimidinic endonuclease (APE/ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis. Mutat Res (1996) 0.99
Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology (1996) 0.99
Maternal coordination of the fetal biological clock in utero. Science (1983) 0.99
Transient compartment syndrome of the forearm after attempted radial artery cannulation. Anesth Analg (1996) 0.99
Definition of the developmental transition from dopaminergic to photic regulation of c-fos gene expression in the rat suprachiasmatic nucleus. Brain Res Mol Brain Res (1995) 0.98
Compartment syndrome of the upper arm after pressurized infiltration of intravenous fluid. J Clin Anesth (1997) 0.97
Maternal suprachiasmatic nuclei are necessary for maternal coordination of the developing circadian system. J Neurosci (1986) 0.96
Adenosine A1 receptors are located predominantly on axons in the rat hippocampal formation. J Comp Neurol (1995) 0.95
Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. Contraception (1999) 0.95
Widespread expression of functional D1-dopamine receptors in fetal rat brain. Brain Res Dev Brain Res (1997) 0.94
Retention of masculine sexual behavior following castration in male B6D2F1 mice. Physiol Behav (1988) 0.94
Vasectomy in the United States, 1991 and 1995. Am J Public Health (1999) 0.94
Gap junctions couple astrocytes but not neurons in dissociated cultures of rat suprachiasmatic nucleus. Brain Res (1996) 0.94
Molecular cloning of a G protein-coupled receptor that is highly expressed in lymphocytes and proliferative areas of developing brain. Mol Cell Neurosci (1992) 0.93
Entrainment of the fetal hamster circadian pacemaker by prenatal injections of the dopamine agonist SKF 38393. J Neurosci (1994) 0.93